Study on Colonic Fermentation in Chronic Kidney Disease Patients
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Jun 7, 2013
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 and ≤ 95 years
- • Treatment with renal replacement therapy, i.e. hemo- or peritoneal dialysis for more than 3 months
- • Written informed consent
- Exclusion Criteria:
- • History of organic gastro-intestinal disease (e.g., inflammatory bowel disease, malignancy)
- • History of colonic surgery
- • Recipient of a renal or other solid organ transplant
- • Use of pre-/pro-/syn- or antibiotics in preceding 4 weeks
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, Vlaams Brabant, Belgium
Patients applied
Trial Officials
Ruben Poesen, MD
Principal Investigator
Universitaire Ziekenhuizen KU Leuven
Björn Meijers, MD, PhD
Principal Investigator
Universitaire Ziekenhuizen KU Leuven
Kristin Verbeke, Pharm PhD
Principal Investigator
Universitaire Ziekenhuizen KU Leuven
Pieter Evenepoel, MD, PhD
Principal Investigator
Universitaire Ziekenhuizen KU Leuven
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials